A Randomized, Double Blind, Multi-center Study to Compare the Efficacy
and Tolerability of Fulvestrant (FASLODEX™) vs Exemestane
(AROMASIN™) in Postmenopausal Women with Hormone
Receptor-Positive Advanced Breast Cancer with Disease Progression after
Prior Non-Steroidal Aromatase Inhibitor (AI) Therapy